Story thread · 2 reports / 2 sources
Arcturus reports phase 2 data for OTC deficiency treatment
investing.com · 7h · first report
The coverage
- Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency
seekingalpha.com · 5h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.